{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:07:01Z","timestamp":1788577621332,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.reth.2025.02.006","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T09:49:58Z","timestamp":1743241798000},"page":"227-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimal frequency of platelet-rich plasma injections for managing osteoarthritis: A longitudinal study"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4373-6854","authenticated-orcid":false,"given":"Masahiko","family":"Kemmochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2025.02.006_bib1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/jcpt.13669","article-title":"Pharmacokinetics, safety and efficacy of intra-articular non-steroidal anti-inflammatory drug injections for the treatment of osteoarthritis: a narrative review","volume":"47","author":"Selig","year":"2022","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.reth.2025.02.006_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/term.3198","article-title":"Wnt5a\/platelet-rich plasma synergistically inhibits IL-1\u03b2-induced inflammatory activity through NF-\u03baB signaling pathway and prevents cartilage damage and promotes meniscus regeneration","volume":"15","author":"Qi","year":"2021","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.reth.2025.02.006_bib3","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1039\/D1BM01873F","article-title":"VEGF-attenuated platelet-rich plasma improves therapeutic effect on cartilage repair","volume":"10","author":"Lee","year":"2022","journal-title":"Biomater Sci"},{"key":"10.1016\/j.reth.2025.02.006_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jos.2016.07.009","article-title":"Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations","volume":"21","author":"Kobayashi","year":"2016","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.reth.2025.02.006_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jor.2019.11.041","article-title":"Clinical outcomes following injections of leukocyte-rich platelet-rich plasma in osteoarthritis patients","volume":"18","author":"Kenmochi","year":"2020","journal-title":"J Orthop"},{"key":"10.1016\/j.reth.2025.02.006_bib6","doi-asserted-by":"crossref","first-page":"364S","DOI":"10.1177\/1947603520931170","article-title":"PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials","volume":"13","author":"Filardo","year":"2021","journal-title":"Cartilage"},{"key":"10.1016\/j.reth.2025.02.006_bib7","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1177\/03635465231224463","article-title":"Platelet-rich plasma versus alternative injections for osteoarthritis of the knee: a systematic review and statistical fragility index-based meta-analysis of randomized controlled trials","volume":"29","author":"Oeding","year":"2024","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.reth.2025.02.006_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reth.2025.02.006_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT-OARSI initiative: osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.reth.2025.02.006_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2106\/JBJS.16.00793","article-title":"Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells","volume":"99","author":"Murray","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.reth.2025.02.006_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12917-017-1123-3","article-title":"Optimisation of a double-centrifugation method for preparation of canine platelet-rich plasma","volume":"13","author":"Shin","year":"2017","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.reth.2025.02.006_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.reth.2025.02.006_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2519\/jospt.1998.28.2.88","article-title":"Knee injury and osteoarthritis outcome score (KOOS) \u2013 development of a self-administered outcome measure","volume":"28","author":"Roos","year":"1998","journal-title":"J Orthop Sports Phys Ther"},{"key":"10.1016\/j.reth.2025.02.006_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.joca.2011.05.004","article-title":"Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score)","volume":"19","author":"Hunter","year":"2011","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.reth.2025.02.006_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Software"},{"key":"10.1016\/j.reth.2025.02.006_bib16","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.reth.2025.02.006_bib17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/leu.2011.389","article-title":"Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?","volume":"26","author":"Ratajczak","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.reth.2025.02.006_bib18","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00784-016-1719-1","article-title":"Comparative release of growth factors from PRP, PRF, and advanced-PRF","volume":"20","author":"Kobayashi","year":"2016","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.reth.2025.02.006_bib19","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00402-021-04230-2","article-title":"Multiple platelet-rich plasma injections are superior to single PRP injections or saline in osteoarthritis of the knee: the 2-year results of a randomized, double-blind, placebo-controlled clinical trial","volume":"142","author":"Yurtbay","year":"2022","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.reth.2025.02.006_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13018-024-04736-6","article-title":"The varying clinical effectiveness of single, three and five intraarticular injections of platelet-rich plasma in knee osteoarthritis","volume":"19","author":"Zhuang","year":"2024","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.reth.2025.02.006_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/19476035231166127","article-title":"Knee osteoarthritis: clinical and MRI outcomes after multiple intra-articular injections with expanded autologous adipose-derived stromal cells or platelet-rich plasma","volume":"14","author":"Khoury","year":"2023","journal-title":"Cartilage"},{"key":"10.1016\/j.reth.2025.02.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcot.2022.101762","article-title":"Chondroprotective effects of multiple PRP injections in osteoarthritis by apoptosis regulation and increased aggrecan synthesis- immunohistochemistry based Guinea pig study","volume":"25","author":"Patel","year":"2022","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.reth.2025.02.006_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1302\/0301-620X.104B6.BJJ-2021-1109.R2","article-title":"The effectiveness of leucocyte-poor platelet-rich plasma injections on symptomatic early osteoarthritis of the knee: the PEAK randomized controlled trial","volume":"104\u2013B","author":"Lewis","year":"2022","journal-title":"Bone Joint Lett J"},{"key":"10.1016\/j.reth.2025.02.006_bib24","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1080\/14712598.2020.1798925","article-title":"Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system","volume":"20","author":"Kon","year":"2020","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.reth.2025.02.006_bib25","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.3390\/jcm10194514","article-title":"Predictors of effectiveness of platelet-rich plasma therapy for knee osteoarthritis: a retrospective cohort study","volume":"10","author":"Saita","year":"2021","journal-title":"J Clin Med"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235232042500032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235232042500032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:33:40Z","timestamp":1763699620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235232042500032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":25,"alternative-id":["S235232042500032X"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2025.02.006","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal frequency of platelet-rich plasma injections for managing osteoarthritis: A longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}